G R Scott Budinger Selected Research

Hypertrophy

1/2022

Lung Injury Induces Alveolar Type 2 Cell Hypertrophy and Polyploidy with Implications for Repair and Regeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G R Scott Budinger Research Topics

Disease

19	Fibrosis (Cirrhosis) 06/2021 - 10/2005
18	Lung Injury 01/2020 - 01/2005
17	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2021 - 03/2006
15	Pneumonia (Pneumonitis) 10/2021 - 03/2006
15	Hypoxia (Hypoxemia) 01/2018 - 04/2002
13	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2022 - 01/2005
10	Infections 12/2020 - 01/2012
8	COVID-19 04/2022 - 01/2020
8	Lung Diseases (Lung Disease) 01/2021 - 02/2015
7	Human Influenza (Influenza) 01/2020 - 01/2012
7	Inflammation (Inflammations) 01/2020 - 06/2011
7	Acute Lung Injury 03/2015 - 01/2005
7	Hyperoxia 01/2012 - 05/2002
6	Thrombosis (Thrombus) 10/2021 - 10/2007
5	Primary Graft Dysfunction 01/2022 - 10/2016
5	Hypercapnia 01/2020 - 01/2012
4	Asthma (Bronchial Asthma) 01/2022 - 01/2015
4	Idiopathic Pulmonary Fibrosis 06/2021 - 09/2011
4	Neoplasms (Cancer) 01/2020 - 05/2010
3	Critical Illness (Critically Ill) 01/2022 - 04/2013
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2010
2	Ventilator-Associated Pneumonia 12/2020 - 09/2005
2	Lymphadenopathy 12/2017 - 10/2015
2	Splenomegaly 12/2017 - 10/2015
2	Respiratory Hypersensitivity 01/2016 - 02/2015
2	Systemic Scleroderma (Systemic Sclerosis) 01/2016 - 11/2011
2	Disease Progression 04/2015 - 07/2014
2	Lung Neoplasms (Lung Cancer) 01/2012 - 05/2010
1	Polyploidy 01/2022
1	Hypertrophy 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Superinfection 10/2021
1	Joint Diseases (Joint Disease) 06/2021
1	Osteoarthritis 06/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Disease Susceptibility (Diathesis) 10/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2002
14	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 10/2005
11	Mitochondrial DNA (mtDNA)IBA 06/2021 - 04/2002
8	AsbestosIBA 06/2021 - 01/2015
8	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 05/2002
7	Particulate MatterIBA 10/2021 - 06/2006
7	Adenosine Triphosphatases (ATPase)IBA 11/2017 - 05/2006
6	Interleukin-6 (Interleukin 6)IBA 01/2019 - 04/2005
6	AntioxidantsIBA 12/2017 - 05/2002
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
5	CytokinesIBA 01/2019 - 10/2007
5	CateninsIBA 02/2017 - 11/2011
4	Prostaglandins DIBA 01/2022 - 10/2016
4	Messenger RNA (mRNA)IBA 01/2021 - 09/2011
4	UbiquitinIBA 01/2021 - 05/2006
4	Biological ProductsIBA 10/2017 - 02/2015
4	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2015 - 02/2012
4	Oxygen (Dioxygen)IBA 04/2013 - 02/2004
4	Adenosine Triphosphate (ATP)IBA 05/2010 - 01/2007
4	Cytochromes c (Cytochrome c)IBA 02/2004 - 04/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 10/2015
3	InflammasomesIBA 01/2021 - 03/2015
3	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2020 - 06/2007
3	Small Interfering RNA (siRNA)IBA 01/2018 - 05/2006
3	CollagenIBA 01/2017 - 09/2011
3	Transcription Factors (Transcription Factor)IBA 05/2013 - 04/2002
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2010 - 01/2005
3	Superoxide DismutaseIBA 07/2006 - 02/2004
3	Caspase 9IBA 05/2002 - 04/2002
2	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2015
2	Crocidolite Asbestos (Blue Asbestos)IBA 06/2021 - 01/2015
2	Sirtuin 3IBA 06/2021 - 01/2017
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 02/2019 - 01/2019
2	protein kinase C zetaIBA 11/2017 - 09/2014
2	Methacholine Chloride (Methacholine)FDA Link 01/2016 - 02/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 01/2013
2	CaspasesIBA 10/2015 - 02/2004
2	Laminin (Merosin)IBA 04/2015 - 09/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015 - 05/2002
2	LeptinIBA 01/2014 - 06/2011
2	Proteasome InhibitorsIBA 02/2012 - 05/2006
2	Oxidants (Oxidizing Agents)IBA 06/2011 - 04/2011
2	EUK-134IBA 05/2009 - 02/2004
2	Rieske iron-sulfur proteinIBA 06/2007 - 05/2006
2	CatalaseIBA 05/2006 - 02/2004
1	Interleukin-12 (IL 12)IBA 01/2022
1	OvalbuminIBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 06/2021
1	VaccinesIBA 01/2021
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 01/2021

Therapy/Procedure

14	Therapeutics 06/2021 - 02/2010
12	Lung Transplantation 01/2022 - 01/2016
6	Transplantation 01/2021 - 07/2014
4	Extracorporeal Membrane Oxygenation 04/2022 - 11/2018
3	Mechanical Ventilators (Ventilator) 04/2022 - 01/2016
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 11/2018
1	Renal Dialysis (Hemodialysis) 01/2022
1	Operative Time 01/2022
1	Pneumonectomy (Lung Volume Reduction) 01/2021
1	Blood Transfusion (Blood Transfusions) 10/2020